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BACKGROUND AND PURPOSE: Research exploring the utility of cardiovascular health (CVH) and its Life’s Simple 7 (LS7) 
components (body mass index, blood pressure [BP], glucose, cholesterol, physical activity, smoking, and diet) for prevention 
of stroke in older adults is limited. In the British Regional Heart Study, we explored (1) prospective associations of LS7 
metrics and composite CVH scores with, and their impact on, stroke in middle and older age; and (2) if change in CVH was 
associated with subsequent stroke.
METHODS: Men without cardiovascular disease were followed from baseline recruitment (1978–1980), and again from re-
examination 20 years later, for stroke over a median period of 20 years and 16 years, respectively. LS7 were measured at 
each time point except baseline diet. Cox models estimated hazard ratios (95% CI) of stroke for (1) ideal and intermediate 
versus poor levels of LS7; (2) composite CVH scores; and (3) 4 CVH trajectory groups (low-low, low-high, high-low, high-
high) derived by dichotomising CVH scores from each time point across the median value. Population attributable fractions 
measured impact of LS7.
RESULTS: At baseline (n=7274, mean age 50 years), healthier levels of BP, physical activity, and smoking were associated with 
reduced stroke risk. At 20-year follow-up (n=3798, mean age 69 years) only BP displayed an association. Hazard ratios for 
intermediate and ideal (versus poor) levels of BP 0.65 (0.52–0.81) and 0.40 (0.24–0.65) at baseline; and 0.84 (0.67–1.05) 
and 0.57 (0.36–0.90) at 20-year follow-up. With reference to low-low trajectory, the low-high trajectory was associated 
with 40% reduced risk, hazard ratio 0.60 (0.44–0.83). Associations of CVH scores weakened, and population attributable 
fractions of LS7 reduced, from middle to old age; population attributable fraction of nonideal BP from 53% to 39%.
CONCLUSIONS: Except for BP, CVH is weakly associated with stroke at older ages. Prevention strategies for older adults should 
prioritize BP control but also enhance focus beyond traditional risk factors.
Key Words: blood pressure ◼ cardiovascular health ◼ cholesterol ◼ life's simple 7 ◼ middle age ◼ older age ◼ prevention ◼ stroke
Stroke remains a major global cause of morbidity and mortality.1 Its incidence rises sharply with age.2 In the United Kingdom, >25 billion pounds ($30 billion) are 
spent annually on stroke care and stroke related disabil-
ity. With more adults surviving to older ages, this burden 
is expected to increase.3
Primary prevention is seen as the best approach to 
reducing the burden of stroke.4 The European Stroke 
Organisation and Stroke Alliance For Europe emphasize 
both risk factor modification and improved stroke risk 
assessment as means to improve primary prevention in 
their latest European Stroke Action Plan.5 A risk factor 
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based model of cardiovascular health (CVH) was devel-
oped by the American Heart Association in 2010 for 
prevention of cardiovascular disease (CVD) and stroke.6 
CVH is measured using 7 traditional health metrics: 
smoking, body mass index (BMI), physical activity (PA), 
diet patterns, total cholesterol, blood pressure (BP), and 
fasting glucose, referred to as Life’s Simple 7 (LS7). Pop-
ulation prevalences of ideal, intermediate, or poor levels 
of each metric, and of summary CVH scores based on 
all 7 metrics, have been explored in association with a 
range of CVD outcomes7,8 to identify metrics that can be 
targeted as part of health promotion programs.
Most studies, however, have either evaluated stroke as 
a combined end point within CVD9–13; are constrained by 
examining CVH at middle age14,15; or have limited follow-
up.13,15,16 Few have analyzed how CVH relates specifically 
to stroke in older populations.17,18 Similarly, there is lim-
ited clarity on how transitions in CVH over time can influ-
ence stroke incidence at an older age.19–21 These issues 
are essential to explore because associations between 
conventional risk factors and CVD weaken with age due 
to a selection of survivors.22–24 Second, despite some 
shared risk factors, stroke epidemiology and etiology  
is somewhat distinct from broader CVD outcomes.7,25 
Stroke prevention strategies for older adults may hence 
require a different focus.
To assess the influence of CVH on incidence of stroke 
in older age, we used data from the BRHS (British 
Regional Heart Study), which has been following cardio-
vascular outcomes in a representative cohort of British 
men for >40 years. Our specific aims were to (1) com-
pare associations between LS7 metrics, composite CVH 
scores, and stroke in middle and older age; (2) explore if 
change in CVH between middle and older age was asso-
ciated with subsequent stroke incidence; and (3) deter-
mine the impact of LS7 metrics on the burden of stroke 
across middle and older age.
METHODS
Data supporting the findings of this study are available from 
the study manager (Ms L Lennon; l.lennon@ucl.ac.uk) upon 
reasonable request.
The BRHS recruited 7735 men 40 to 59 years, from 
24 primary care practices across Britain between 1978 and 
1980.26–28 Participants contributed sociodemographic, health, 
medication, and lifestyle data through questionnaires and 
underwent objective and lab-based examinations, including 
an ECG, at baseline29,30 and 20-year follow-up (Q20).27,28 This 
analysis used information on LS7 metrics collected at both time 
points together with CVD events and deaths to June 2018. All 
participants provided written informed consent in accordance 
with the Declaration of Helsinki. Ethical approval was obtained 
from relevant local research ethics committees.
Assessment of CVH
LS7 metrics were measured objectively except for smoking, PA, 
and diet which were self-reported. Diet was measured at Q20 
only.31 Metrics were categorized as poor, intermediate, and ideal 
using American Heart Association definitions except smoking, 
PA and diet, which were classified using BRHS specific cut-
offs29,31–37 (details in Table I in the Data Supplement).
Composite CVH scores were sum of points (0, 1, 2, respec-
tively) assigned to poor, intermediate, and ideal levels of each 
LS7 metric. CVH scores ranged from 0 to 12 at baseline 
(dietary information was not available) and 0 to 14 at Q20. 
Lower scores indicated poorer CVH. CVH categories38 were 
derived from CVH score as inadequate (0–4 baseline and 
Q20), average (5–8 baseline, 5–9 Q20), and optimum (9–12 
baseline, 10–14 Q20).
For capturing change in CVH from baseline to Q20, CVH 
trajectories were derived using CVH scores (exclusive of diet, 
range 0–12) from each time point. Scores were dichotomized 
using the median value. A score ≤7 was classed as low and >7 
as high CVH; hence each participant belonged to one of 4 CVH 
trajectory groups: low-low, low-high, high-low, and high-high.
Ascertainment of Stroke, Myocardial Infarction, 
and Mortality
Participants were followed up for mortality and nonfatal stroke 
and myocardial infarction (MI). Deaths were collected through 
National Health Service Central Registers in Southport (for 
England and Wales) and Edinburgh (for Scotland), with cause 
of death coded using the International Classification of Diseases, 
Ninth Revision. Fatal stroke was coded as 430–438 and fatal 
MI as 410–414.
Nonfatal events were ascertained from ongoing general 
practitioner reports and biennial reviews of participants’ medical 
records.27 Nonfatal MI was defined according to World Health 
Organization criteria39 and nonfatal stroke as an event produc-
ing a neurological deficit for >24 hours. General practitioners 
were asked to review records of all surviving participants every 
2 years and identify any nonfatal stroke on a standard form. 
In such cases, they were also asked to provide information on 
clinical presentation, hospital record summaries, and results of 
specific investigations where available, including brain scans. 
This material was reviewed by a BRHS clinical assessor, par-
ticularly to exclude any nonstroke diagnoses.
Nonstandard Abbreviations and Acronyms
AF atrial fibrillation
BMI body mass index
BP blood pressure
BRHS British Regional Heart Study
CVD cardiovascular disease
CVH cardiovascular health
HR hazard ratio
LS7 Life’s Simple 7
MI myocardial infarction
PA physical activity
PAF population attributable fraction
Q20 20-year follow-up
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Analyses excluded men with prevalent CVD. Prevalent CVD 
at baseline (stroke, angina, coronary thrombosis, and MI) was 
determined from self-report of physician diagnosis; and at Q20 
if a stroke or MI was noted in record review data before Q20.
Covariates
Self-reported social class (manual, nonmanual and armed 
forces; based on longest held occupation) and alcohol intake 
(none, occasional, light, moderate, and heavy) were recorded 
at both waves.28 Atrial fibrillation (AF) was recorded using a 
12-lead ECG at Q20.
Statistical Analyses
Descriptive statistics compared sociodemographic characteris-
tics, LS7 metrics, composite CVH scores and stroke incidence 
per 1000 person years from baseline and Q20; as well as pro-
files of CVH trajectories. Cox proportional hazards models esti-
mated hazard ratios (HRs) of stroke for individual LS7 metrics, 
CVH scores, and trajectory groups. Time to event was calcu-
lated from the baseline/Q20 date of examination to a stroke 
event or death, whichever came first. For participants with nei-
ther event, data was censored at the Q20 date for baseline and 
June 1, 2018 for Q20 analysis, respectively. Adjustments were 
made for social class at baseline and age and alcohol intake 
at the respective time point. Proportional hazards assumptions 
examined using Schoenfeld residuals were found to hold.
Associations were based on available complete cases. 
However, in sensitivity analyses, we investigated characteristics 
of men with missing covariates; and robustness of associations 
by assigning the worst possible LS7 level (poor) to those with 
missing data on any LS7.
Analyses were conducted using Stata software version 15 
(StataCorp LLC, Texas). To explore how useful LS7 metrics 
were at discriminating between cases and noncases of stroke, 
we compared Harell’s C statistics of multivariate models at 
baseline and Q20. We also compared the fraction of incident 
stroke attributable to individual LS7 metrics-population attrib-
utable fraction (PAF) at each time point, using the punafcc40 
package for Stata, evaluating the scenario where all partici-
pants had the metric in question at the ideal level.
We examined whether excluding men with prevalent heart 
failure (n=73, 2%) and those with ECG evidence of AF (n=122, 
3%) at Q20 affected results; and further explored associations 
between LS7 metrics, CVH scores, trajectories and a CVD out-
come of stroke and MI combined.
RESULTS
LS7 and Composite CVH Scores
There were 7274 men (mean age 50 years) without 
prevalent CVD at baseline. After a median follow-up 
of 19.8 years, 434 fatal and nonfatal stroke events 
occurred at a rate of 3.3/1000 person years. Among 
LS7, glucose (65%) was most and BP (9%) least preva-
lent at ideal levels. Mean composite CVH score was 6.3 
(range, 0–12), with 71% men in the average and only 
12% in the optimal CVH category (Figure 1 and Table II 
in the Data Supplement).
At Q20, there were 3798 men (mean age 69 years) 
without prevalent CVD. After a median follow-up of 
15.7 years, there were 446 stroke events at a rate of 
8.7/1000 person years. Among measured LS7, smoking 
status (84%) was most and BP (7%) least prevalent at 
ideal levels. Mean composite CVH score was 7.7 (range, 
0–14; exclusive of diet: mean 6.8, range 0–12), with 
76% of men in the average and 18% in the optimal CVH 
category (Figure 1 and Table II in the Data Supplement).
Cox regression of individual LS7 metrics (Table 1) 
revealed that at younger ages, healthier levels of BP, 
PA, and smoking status were associated with reduced 
risk of stroke. Compared with poor levels, adjusted HRs 
(95% CI) for intermediate and ideal levels were, respec-
tively, 0.65 (0.52–0.81) and 0.40 (0.24–0.65) for BP; 
0.79 (0.58–1.08) and 0.63 (0.45–0.88) for PA; and 0.69 
(0.56–0.86) and 0.59 (0.45–0.78) for smoking. Favour-
able trends were also seen for better BMI and glucose 
levels although not statistically significant at a conven-
tional cutoff of P=0.05. A unit increase in composite 
CVH score was associated with 16% reduced risk of 
stroke, adjusted HR 0.84 (0.79–0.89). Better categories 
of overall CVH were also protective for stroke: compared 
with the inadequate category, an average to optimal CVH 
status was associated with between a 40% to 60% 
reduction in HRs (P for trend <0.0001).
At Q20, BP was the only LS7 metric showing a clear (but 
attenuated) association with subsequent stroke. Compared 
with poor BP, adjusted HRs for intermediate and ideal lev-
els were 0.84 (0.67–1.05) and 0.57 (0.36–0.90), respec-
tively, P for trend 0.0168 (Table 1). Each unit increase in 
composite CVH score was associated with 5% reduced 
risk of stroke (adjusted HR, 0.95 [0.90–1.01]). Associa-
tions between CVH score categories and stroke similarly 
became weaker and nonsignificant, P for trend 0.1394.
Trajectories of CVH Between Baseline and Q20
A fifth of men maintained high CVH from baseline to Q20 
(n=641), while more than half had persistently low CVH 
over the same period (n=1740). Five hundred and sixty 
three men improved their CVH from low to high, while 
CVH of 425 men deteriorated from high to low (Table 2). 
Incidence rates (95% CI) of stroke per 1000 person 
years were low-low 9.8 (8.6–11.2); low-high 6.2 (4.7–
8.2); high-low 7.3 (5.5–9.8); and high-high 7.9 (6.3–9.8). 
In comparison to low-low, all remaining groups showed 
reduced probabilities of stroke (Figure 2). Low-high in 
particular had a 40% reduced stroke risk (adjusted HR, 
0.60 [95% CI, 0.44–0.83]).
Excluding men with heart failure and AF at Q20 did 
not materially affect results of the above analyses.
Less than 3% of the men had missing data at baseline. 
At Q20, a maximum of 18% of the men had missing covari-
ates. These men were slightly older with a higher incidence 
of stroke but with similar mean BPs and smoking habits to 
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those with complete data (Table III in the Data Supplement). 
The men had poorer CVH at baseline. However, associa-
tions were robust even in analyses that assumed a poor 
level for missing LS7 data (Table IV in the Data Supplement).
Impact of LS7 Across Time
In multivariable models containing all LS7 metrics except 
diet; and adjusted for age, social class and alcohol intake, 
Harrell C statistic decreased from 0.7103 at baseline to 
0.6548 at Q20. The PAFs of LS7 metrics also decreased 
over time (Table V in the Data Supplement). Notably, the 
burden of stroke that could be eliminated by control of high 
BP reduced from 53% in middle age to 39% in older age.
CVH and a Combined CVD Outcome
All LS7 metrics measured at Q20, except BMI and cho-
lesterol, showed significant associations in expected 
directions with MI and stroke combined (Table VI in the 
Data Supplement). In analysis comparing trajectories 
to low-low, all groups had significantly reduced risk of 
a combined CVD outcome with high-high and low-high 
groups having a risk reduction of similar magnitude.
DISCUSSION
This prospective analysis assessed the associations and 
impact of CVH and its component LS7 metrics on stroke 
burden, during middle and older ages in a general popu-
lation sample of British men free of CVD.
We noted that BP, PA, and smoking at baseline were 
associated with stroke in middle age, but only BP main-
tained a clear (albeit weaker) inverse association with 
stroke in later life. Others looking at older subjects16,23,41 
have established the influence of BP on stroke across 
the life-course. Our findings reaffirm its value as a key 
target in stroke prevention strategies. However, we 
Figure 1. Proportions of LS7 metrics at baseline and at 20 y follow-up (Q20) among men of the British Regional Heart study 
free of prevalent cardiovascular disease.
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Table 1. Hazard Ratios [95% CI] for Stroke Among Men in the BRHS, Free of Prevalent CVD at Baseline and at Q20
Baseline 1978–1980* Q20 1998–2000†
Model 1 Model 2 Model 1 Model 2
BMI N=7273 N=7256 N=3783 N=3717
 Poor 1 1 1 1
 Intermediate 0.79 [0.57–0.10] 0.81 [0.58–1.13] 1.20 [0.90–1.60] 1.22 [0.91–1.62]
 Ideal 0.72 [0.52–1.00] 0.75 [0.54–1.05] 1.18 [0.87–1.60] 1.19 [0.87–1.62]
 P for trend 0.0524 0.0950 0.2982 0.2720
BP N=7267 N=7250 N=3779 N=3713
 Poor 1 1 1 1
 Intermediate 0.63 [0.51–0.79] 0.65 [0.52–0.81] 0.86 [0.69–1.08] 0.84 [0.67–1.05]
 Ideal 0.38 [0.23–0.62] 0.40 [0.24–0.65] 0.57 [0.36–0.91] 0.57 [0.36–0.90]
 P for trend 0.0001 0.0002 0.0190 0.0168
Glucose N=7228 N=7211 N=3590 N=3528
 Poor 1 1 1 1
 Intermediate 0.86 [0.62–1.20] 0.88 [0.63–1.23] 0.87 [0.62–1.22] 0.85 [0.61–1.20]
 Ideal 0.72 [0.53–0.98] 0.74 [0.54–1.01] 0.79 [0.56–1.11] 0.78 [0.55–1.09]
 P for trend 0.0397 0.0617 0.1762 0.1467
Cholesterol N=7232 N=7215 N=3618 N=3556
 Poor 1 1 1 1
 Intermediate 1.04 [0.85–1.27] 1.03 [0.84–1.26] 0.87 [0.70–1.08] 0.85 [0.69–1.06]
 Ideal 0.87 [0.65–1.17] 0.84 [0.63–1.14] 1.07 [0.84–1.38] 1.09 [0.85–1.40]
 P for trend 0.3625 0.2659 0.5800 0.4981
Physical activity N=7178 N=7163 N=3665 N=3616
 Poor 1 1 1 1
 Intermediate 0.78 [0.57–1.06] 0.79 [0.58–1.08] 1.01 [0.71–1.44] 1.02 [0.71–1.45]
 Ideal 0.59 [0.42–0.82] 0.63 [0.45–0.88] 0.86 [0.60–1.22] 0.88 [0.62–1.26]
 P for trend 0.0018 0.0066 0.3900 0.4988
Smoking N=7260 N=7244 N=3792 N=3727
 Poor 1 1 1 1
 Intermediate 0.66 [0.54–0.82] 0.69 [0.56–0.86] 0.57 [0.25–1.34] 0.57 [0.25–1.34]
 Ideal 0.54 [0.41–0.71] 0.59 [0.45–0.78] 0.86 [0.64–1.14] 0.86 [0.64–1.16]
 P for trend <0.0001 0.0002 0.2933 0.3266
Elderly diet index   N=3512 N=3452
 Poor … … 1 1
 Intermediate … … 1.08 [0.86–1.35] 1.13 [0.89–1.42]
 Ideal … … 1.01 [0.78–1.30] 1.06 [0.82–1.37]
 P for trend … … 0.9413 0.6780
Composite CVH score N=7112 N=7097 N=3177 N=3135
 Per unit increase 0.83 [0.78–0.87] 0.84 [0.79–0.89] 0.95 [0.90–1.00] 0.95 [0.90–1.01]
CVH score categories‡
 Inadequate 1 1 1 1
 Average 0.56 [0.45–0.70] 0.59 [0.47–0.73] 0.71 [0.45–1.10] 0.73 [0.46–1.15]
 Optimal 0.35 [0.23–0.54] 0.39 [0.25–0.61] 0.65 [0.40–1.07] 0.68 [0.41–1.13]
 P for trend <0.0001 <0.0001 0.0924 0.1394
Model 1 adjusted for age. Model 2 adjusted additionally for social class and alcohol intake at baseline/Q20. BMI indicates body mass index; BP, blood pressure; 
BRHS, British Regional Heart Study; CVD, cardiovascular disease; CVH, cardiovascular health; and Q20, 20y follow-up.
*Followed from baseline to Q20.
†Followed from Q20 to June 2018.
‡Inadequate: 0–4 baseline and Q20, average: 5–8 baseline/5–9 Q20, and optimal: 9–12 baseline/10–14 Q20.
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highlight that the burden of stroke which can potentially 
be eliminated by achieving ideal BP control decreases 
with increasing age. Our PAF (39%) among older men 
(versus 53% at baseline), of BP higher than the ideal (of 
untreated 120/80 mm Hg) is similar to that estimated 
by the Rotterdam study42 among men of a similar mean 
age (69y) as BRHS; and to the PAF of hypertension 
calculated (with a higher cutoff) among European partici-
pants of the INTERSTROKE study43 (which also noted 
hypertension as a stronger risk factor in those <55 
years). It is likely that even this (39%) is an overestimate, 
since in reality all men of older age are unlikely to attain 
ideal BP as defined by the American Heart Associa-
tion. It has in fact been observed that among those ≥80 
Table 2. Profiles of CVH Trajectories and Hazard Ratios [95% CI] for stroke Among Men in the BRHS, 
Free of Prevalent CVD at Q20
CVH Trajectories Over 20 Years*
Low-Low (N=1740) Low-High (N=563) High-Low (N=425) High-High (N=641)
Stroke events (n) 217 48 46 78
Incidence rate per 1000 PY (95% CI) 9.8 (8.6–11.2) 6.2 (4.7–8.2) 7.3 (5.5–9.8) 7.9 (6.3–9.8)
Age, y† 69 (5.4) 69 (5.5) 67 (5.2) 67 (5.4)
Social class
 Nonmanual 41 46 56 59
 Manual 56 51 42 39
 Armed forces 3 3 2 2
BMI, kg/m2† 27.9 (3.8) 25.6 (3.1) 26.7 (3.0) 24.8 (2.6)
 Poor 25 4 13 2
 Intermediate 56 50 63 39
 Ideal 19 46 23 58
BP, mm Hg
 Sitting systolic† 156 (23) 144 (23) 152 (21) 138 (24)
 Sitting diastolic† 87 (11) 83 (10) 88 (10) 83 (11)
 Poor 79 51 77 44
 Intermediate 19 37 21 39
 Ideal 2 12 2 17
Glucose, mmol/L† 6.4 (2.2) 5.5 (0.9) 5.9 (1.0) 5.5 (0.7)
 Poor 16 1 6 1
 Intermediate 49 30 55 31
 Ideal 36 69 40 68
Cholesterol, mmol/L† 6.3 (1.1) 5.6 (0.9) 6.2 (1.0) 5.5 (0.9)
 Poor 52 15 53 17
 Intermediate 36 50 36 43
 Ideal 12 35 11 40
Physical activity
 Poor 15 2 11 3
 Intermediate 50 28 49 28
 Ideal 35 70 40 70
Smoking
 Poor 20 4 10 3
 Intermediate 5 1 1 1
 Ideal 75 95 88 97
Composite CVH score†‡ 5.7 (1.2) 8.5 (0.7) 6.3 (0.9) 8.8 (0.9)
Hazard ratio (95% CI)§ 1 0.60 (0.44–0.83) 0.83 (0.60–1.15) 0.86 (0.66–1.12)
Profiles are as at Q20. Numbers are rounded percentages unless indicated. BMI indicates body mass index; BP, blood pressure; BRHS, 
British Regional Heart Study; CVD, cardiovascular disease; CVH, cardiovascular health; PY, person year; and Q20, 20y follow-up.
*N=3369, stroke events=389 for men followed from 1998/2000 to June 2018.
†Mean (SD).
‡Range 0–12 excluding diet.
§Adjusted for social class at baseline, age, and alcohol intake at Q20, N=3323.
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years, the PAF for stroke due to hypertension becomes 
insignificant.44
Apart from BP, no other LS7 metrics individually influ-
enced stroke in older men. Accordingly, higher (healthier) 
composite CVH scores at older ages offered weaker 
protection against stroke. The C statistic for our multivar-
iate Q20 model, similar to that recorded by Dong et al17 
among participants of a comparable age, also reflects 
the weak ability of these metrics to jointly, correctly clas-
sify stroke events from nonevents at older age.
These findings underscore the need to optimize the 
detection and management of wider conditions known to 
increase the risk of stroke in older populations. Research 
from primary care in the United Kingdom indicates that 
both screening of AF among those >65 years45 and its 
anticoagulation management among those >85 years46 
can be improved. More recently, aging related atrial car-
diopathy has been linked to stroke independent of AF.47 
Other risk factors to direct prevention strategies towards 
include subclinical cardiac dysfunction48 and impaired 
kidney function, which has been recently highlighted to 
increase in impact with increasing life span.49
Our analysis using a composite end point of MI and 
stroke observed that among older men, most individual 
LS7 metrics as well as CVH score categories exhibited 
clear expected associations with combined CVD. This 
may reflect greater influence of conventional factors in 
old age on coronary outcomes as opposed to stroke, and 
has also been noted among Swedish men.41 It further 
suggests that health promotion targeting conventional 
factors such as LS7 among older adults would be less 
likely to reduce the burden of stroke in contrast to MI.
Nevertheless, the trajectory analysis indicated that the 
importance of adopting and maintaining a healthy life-
style even in later life cannot be undermined. In previous 
work analyzing associations of change in CVH status with 
broad CVD outcomes, Enserro et al21 using data from the 
Framingham Offspring study concluded that irrespective 
of whether they improved or not, people starting with low 
CVH status had higher rates of composite CVD com-
pared with those maintaining high CVH throughout the 
study period. Analysis of Whitehall II data using a more 
precise categorization of CVH trajectories (9 groups) 
failed to show consistent associations with incident 
CVD.19 In comparison, older BRHS men who improved 
CVH from low to high had reduced risk of stroke and 
MI combined, of a magnitude similar to that offered by 
maintaining high CVH throughout life. This suggests that 
later life CVH has a greater bearing on subsequent CVD. 
We further noted this benefit, although not as large, for 
stroke alone. Yang et al50 do identify a similar protective 
trend against stroke from positive changes in CVH but 
among a younger Chinese cohort and over a shorter tran-
sition period. We must point out, however, that we cannot 
identify the exact time between baseline and Q20 when 
men may have transitioned in CVH status, or indeed, if 
there was >1 transition. Exposure durations may hence 
be variable and hazards may not accurately reflect this. 
Moreover, although similar to the creation of trajectory 
groups by others,21 our binary CVH score cutoff is arbi-
trarily based on the median for both baseline and Q20.
Our study is novel in its exploration of CVH and its 
association with stroke as a specific outcome during 
both middle and older age within the same population; 
with near complete follow-up, over an extended period. 
Stroke capture has been reliable—the incidence rates of 
stroke during both middle and older age observed using 
the study protocol have been comparable with national 
data.51,52 Furthermore, we based our analyses on the full 
range of CVH score (0–12/14) as opposed to only an 
aggregate of ideal LS7 metrics (0–6/7). This takes into 
account intermediate levels of a metric and may be more 
realistic for older ages when drug therapies for diabetes 
mellitus, dyslipidemia, and hypertension preclude ideal 
levels of these metrics. It is worth noting here that less 
than a fifth of our older men attained an optimal compos-
ite CVH score needing ≥5 metrics at the ideal level.
Men participating in the BRHS are of predominantly 
White ethnicity so generalizability of our findings to women 
and wider British population groups will be limited; however, 
findings are still relevant to a large section of the contem-
porary older population in the United Kingdom. Additionally, 
we lacked a measure of diet at baseline and in deriving 
CVH trajectories. However, the utility of an overall dietary 
score may be less consistent with respect to stroke/
CVD.14,16,18 Finally, we were unable to classify stroke into 
its subtypes and acknowledge that observed associations 
may not apply equally to ischemic and hemorrhagic stroke.
CONCLUSIONS
With the exception of BP, CVH is weakly associated with 
stroke at older ages. Stroke prevention strategies should 
Figure 2. Stroke free probability curves in cardiovascular 
health trajectory groups among men free of prevalent 
cardiovascular disease at 20 y of follow-up; adjusted for age, 
social class, and alcohol intake.
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prioritize control of BP and energize efforts beyond tradi-
tional risk factors towards better detection and manage-
ment of wider causes, including AF. Research into stroke 
prevention in older adults should also consider potential 
subclinical conditions such as cardiac and kidney dys-
function that can influence stroke burden.
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